Legend Biotech (LEGN) Profit After Tax (2019 - 2025)
Legend Biotech (LEGN) posted Profit After Tax of $30.9 million for Q4 2025, down 22.14% quarter-over-quarter from $39.7 million in Q3 2025, and up 17.05% year-on-year from $26.4 million in Q4 2024.
Legend Biotech (LEGN) Profit After Tax (2019 - 2025) Analysis & Trends
Legend Biotech (LEGN) has reported Profit After Tax for 7 consecutive years, with $30.9 million the latest figure, recorded in Q4 2025.
- Profit After Tax for Q4 2025 came in at $30.9 million, up 17.05% year-over-year; the trailing twelve-month figure through Dec 2025 was $98.6 million (down 10.45% YoY), and the FY2025 annual result was -$296.8 million, down 67.68% from the prior year.
- Profit After Tax was $30.9 million for Q4 2025 at Legend Biotech, down from $39.7 million in the prior quarter.
- Over five years, Profit After Tax peaked at $535.4 million in Q3 2022 and troughed at -$410.8 million in Q4 2021.
- Average Profit After Tax over 5 years is -$17.6 million, with a median of -$16.1 million recorded in 2022.
- Year-over-year, Profit After Tax sank 32288.91% in 2022 and surged 18329.78% in 2024.
- Over 5 years, Profit After Tax stood at -$410.8 million in 2021, then soared by 67.0% to -$135.6 million in 2022, then jumped by 99.89% to -$144818.0 in 2023, then soared by 18329.78% to $26.4 million in 2024, then advanced by 17.05% to $30.9 million in 2025.
- Per Business Quant data, the three most recent Profit After Tax figures were $30.9 million in Q4 2025, $39.7 million in Q3 2025, and $125.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | 53.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | -14.46 Mn |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 227.36 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 1.03 Bn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | -4.45 Mn |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 378.00 Mn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 205.99 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | -453.82 Mn |
| 10 | Legend Biotech | 11.04 Bn | 10.14 Bn | 242.10 Mn | -30.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30.90 Mn |
| Sep 30, 2025 | 39.69 Mn |
| Jun 30, 2025 | 125.38 Mn |
| Mar 31, 2025 | -97.34 Mn |
| Dec 31, 2024 | 26.40 Mn |
| Sep 30, 2024 | 125.32 Mn |
| Jun 30, 2024 | 18.20 Mn |
| Mar 31, 2024 | -59.78 Mn |
| Dec 31, 2023 | -144.82 Mn |
| Sep 30, 2023 | -684.41 Mn |
| Jun 30, 2023 | 423.07 Mn |
| Mar 31, 2023 | -111.85 Mn |
| Dec 31, 2022 | -135.57 Mn |
| Sep 30, 2022 | 535.35 Mn |
| Jun 30, 2022 | -192.91 Mn |
| Mar 31, 2022 | -31.96 Mn |
| Dec 31, 2021 | -91.95 Mn |
| Sep 30, 2021 | -124.75 Mn |
| Jun 30, 2021 | -172.38 Mn |
| Mar 31, 2021 | -98,685.00 |